UK-based drug design company Exscientia has announced it has entered into a strategic drug discovery partnership with GlaxoSmithKline (GSK). Under this partnership, Exscientia will use its artificial intelligence (AI)-enabled platform, combined with the expertise of GSK, to discover novel and selective small molecules for up to 10 disease-related targets, nominated by GSK across multiple therapeutic areas. It will receive research payments from GSK in lieu of this. Exscientia will also...

Artificial intelligence (AI) and deep learning can help analyse images of a patient’s organs to assess potential diseases and predict their potential lifespan, according to new research. Researchers from the University of Adelaide’s School of Public Health and School of Computer Science, along with Australian and international collaborators, have merged AI and medical images in a first-of-its-kind study. The research was published in the Nature journal Scientific Reports. This...

Gartner has given a tentative guideline of 2022 as when smart machines and robots may replace highly trained professionals in medicine, law and IT, according to the firm’s latest missive. The analyst house argues there is a fear of skilled practices becoming ‘utilities’ through the rise of artificial intelligence (AI). One example Gartner uses is through law; if an enterprise uses a smart machine which substitutes for a lawyer, after the first long and expensive period of training, the...